Mark Strobeck - 14 Mar 2024 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Role
President and CEO, Director
Signature
/s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck
Issuer symbol
RMTI
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
4
Filing time
15 Mar 2024, 16:34:35 UTC
Previous filing
25 Aug 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Award $0 +100,000 +180% $0.000000 155,465 14 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMTI Stock Option (Right to Buy) Award $0 +141,560 $0.000000 141,560 14 Mar 2024 Common Stock 141,560 $1.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units vest in three equal installments on the first, second and third anniversaries of March 14, 2024, subject to the Reporting Person's continued service to the Issuer.
F2 Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 14, 2028, subject to the Reporting Person's continued service to the Issuer.